Technological Innovations in Behavioral Treatments for Cigarette Smoking
- Conditions
- Cigarette Smoking
- Registration Number
- NCT00926939
- Lead Sponsor
- National Development and Research Institutes, Inc.
- Brief Summary
The purpose of the study is to evaluate a sustainable and broadly accessible treatment delivery model (Motiv8) for smoking cessation based on abstinence-reinforcement.
- Detailed Description
Smokers are randomly assigned to one of two groups: an Abstinence Contingent (AC) group and a Submission Contingent (SC) group. The AC group receives vouchers for abstaining from smoking (measured by a carbon monoxide monitor and confirmed through video-submission), and the SC group receives vouchers for submitting videos of their carbon monoxide breath tests. Both groups take videos of their CO-monitoring on a secure website designed for the study, as well as receive standard care counseling and education related to smoking cessation. The main intervention lasts four weeks, and a three-week maintenance phase will follow. Assessments will be conducted at intake, week four (end of the main treatment phase), and at three and six months after the intervention period is completed
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 96
- Self-reported smoker
- Permission to contact applicant by phone
- Ability to use the internet
- Self-report of a history of or current severe or unstable medical or psychiatric illness that would interfere with the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method CO sample of ≤ 4ppm 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention Participant reporting not smoking, not even a puff in the last 7 days. 4 weeks, 7 weeks during intervention; 3 months and 6 months after intervention
- Secondary Outcome Measures
Name Time Method Twice-daily breath CO samples obtained during treatment period. First 4 weeks of treatment The longest duration of sustained abstinence based on the twice-daily breath samples during the treatment period. First 4 weeks of treatment
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
National Development and Research Institutes
🇺🇸New York City, New York, United States
National Development and Research Institutes🇺🇸New York City, New York, United States